Press Releases from Greyston Research Associates (1 total)
Sustained Release Injectables to Exceed $10 Billion in 2015, According To Greyst …
(Amherst, NH) – Engineered formulations of injectable drugs – a class that includes established therapeutics for a number of disease segments including metabolic diseases, neurology and oncology – will experience an annual growth rate of 9.3 percent, exceeding $10 billion in market value by 2015, according to a new and comprehensive analysis by Greystone Research Associates. Growth will be spread across several major indications and will be driven in part…
